Digbi Health Raises $5.4 Million in Series A Funding to Reverse Obesity and Associated Inflammatory Digestive and Skin Illnesses

19 Mar, 2021

Digbi Health Raises $5.4 Million in Series A Funding to Reverse Obesity and Associated Inflammatory Digestive and Skin Illnesses
Photo by Dimitry Anikin on Unsplash

– Digbi Health Raises $5.4 Million in Series A Funding to Reverse Obesity and Associated Inflammatory Digestive and Skin Illnesses
– Digbi Health, a leader in clinically proven genetics and gut-microbiome based digital care program for managing obesity and associated inflammatory digestive, skin and cardiometabolic illnesses, announced it has completed $5.4 million in Series A funding led by Accel, with participation from Wisdom LLP and the company’s Seed round backers Ocean Azul Partners and Seraph Venture.
– The investment brings the total funding raised by the company to $8.5 million since being founded in 2018, and will help the company to deepen its lead in evidence-based, clinically-proven and actionable science of combining genetics, the gut microbiome and clinical risk markers to deliver precision care for chronic inflammatory illnesses.

Health Care North America
Crunchbase icon

Content report

The following text will be sent to our editors: